PExA AB — Investor Relations & Filings

PExA AB is a life science company that develops and commercializes a proprietary, non-invasive technology for respiratory medicine. The company's system collects biomaterial from the small, distal airways by capturing and analyzing particles in exhaled air. This method allows for the sampling of Respiratory Tract Lining Fluid (RTLF), enabling the discovery and analysis of early biomarkers. The technology is designed to advance research, facilitate more accurate diagnostics, and support the development of targeted treatments for various lung diseases. PExA provides its research instruments and services to researchers in academia, healthcare, and the pharmaceutical industry.